Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Renal Cell | 9 | 2025 | 217 | 1.710 |
Why?
|
| Kidney Neoplasms | 10 | 2025 | 403 | 1.640 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 2024 | 77 | 0.980 |
Why?
|
| Testicular Neoplasms | 2 | 2024 | 110 | 0.960 |
Why?
|
| Seminoma | 1 | 2024 | 20 | 0.850 |
Why?
|
| Nephrectomy | 5 | 2025 | 169 | 0.730 |
Why?
|
| Nomograms | 2 | 2025 | 54 | 0.440 |
Why?
|
| Lymph Node Excision | 2 | 2024 | 171 | 0.400 |
Why?
|
| C-Reactive Protein | 2 | 2024 | 410 | 0.370 |
Why?
|
| Lymphatic Metastasis | 2 | 2025 | 352 | 0.260 |
Why?
|
| Neoplasm Staging | 3 | 2025 | 1389 | 0.250 |
Why?
|
| Registries | 2 | 2024 | 2035 | 0.250 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2025 | 1079 | 0.240 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2025 | 11 | 0.240 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2025 | 12 | 0.240 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2025 | 22 | 0.240 |
Why?
|
| Retrospective Studies | 11 | 2025 | 15657 | 0.230 |
Why?
|
| Retroperitoneal Space | 1 | 2024 | 20 | 0.220 |
Why?
|
| Urology | 1 | 2024 | 63 | 0.210 |
Why?
|
| Physicians, Women | 1 | 2024 | 83 | 0.210 |
Why?
|
| Lymphocytes | 1 | 2025 | 397 | 0.200 |
Why?
|
| Extracellular Vesicles | 1 | 2025 | 146 | 0.200 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2025 | 327 | 0.200 |
Why?
|
| Teratoma | 1 | 2024 | 114 | 0.200 |
Why?
|
| Medical Oncology | 1 | 2024 | 289 | 0.190 |
Why?
|
| Robotic Surgical Procedures | 1 | 2024 | 130 | 0.190 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2025 | 252 | 0.190 |
Why?
|
| Survival Rate | 4 | 2025 | 1972 | 0.170 |
Why?
|
| Societies, Medical | 1 | 2024 | 820 | 0.170 |
Why?
|
| Machine Learning | 1 | 2025 | 493 | 0.160 |
Why?
|
| Neutrophils | 1 | 2025 | 1238 | 0.160 |
Why?
|
| Databases, Factual | 1 | 2024 | 1357 | 0.150 |
Why?
|
| Aged | 10 | 2025 | 23961 | 0.140 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2024 | 617 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2024 | 692 | 0.130 |
Why?
|
| Middle Aged | 10 | 2025 | 33479 | 0.120 |
Why?
|
| Prognosis | 4 | 2025 | 4030 | 0.120 |
Why?
|
| Male | 11 | 2025 | 67762 | 0.120 |
Why?
|
| Treatment Outcome | 3 | 2024 | 10811 | 0.120 |
Why?
|
| Postoperative Complications | 1 | 2025 | 2654 | 0.100 |
Why?
|
| Humans | 14 | 2025 | 137585 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2025 | 889 | 0.100 |
Why?
|
| Biomarkers | 1 | 2024 | 4149 | 0.100 |
Why?
|
| Quality of Life | 1 | 2024 | 2892 | 0.090 |
Why?
|
| Female | 10 | 2025 | 73304 | 0.080 |
Why?
|
| Comorbidity | 2 | 2025 | 1622 | 0.080 |
Why?
|
| Biomarkers, Tumor | 2 | 2024 | 1276 | 0.070 |
Why?
|
| Platelet Count | 1 | 2025 | 86 | 0.060 |
Why?
|
| Lymphocyte Count | 1 | 2025 | 148 | 0.060 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2025 | 110 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2024 | 213 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2025 | 510 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2024 | 325 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2024 | 160 | 0.050 |
Why?
|
| Necrosis | 1 | 2024 | 246 | 0.050 |
Why?
|
| Urinary Bladder | 1 | 2025 | 183 | 0.050 |
Why?
|
| Forecasting | 1 | 2024 | 389 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 7635 | 0.050 |
Why?
|
| ROC Curve | 1 | 2024 | 554 | 0.050 |
Why?
|
| DNA Damage | 1 | 2025 | 420 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2025 | 1266 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2024 | 491 | 0.050 |
Why?
|
| Cell Survival | 1 | 2025 | 1120 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2025 | 408 | 0.050 |
Why?
|
| Fibrosis | 1 | 2024 | 552 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2024 | 1325 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2024 | 746 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 2031 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2025 | 1317 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 3412 | 0.030 |
Why?
|
| United States | 2 | 2024 | 14841 | 0.030 |
Why?
|
| Kidney | 1 | 2024 | 1468 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2025 | 3457 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 5742 | 0.030 |
Why?
|
| Adult | 2 | 2025 | 37929 | 0.020 |
Why?
|
| Risk Factors | 1 | 2024 | 10388 | 0.020 |
Why?
|
| Animals | 1 | 2025 | 36940 | 0.010 |
Why?
|